Ed Carr
Oncology Medical Science Liaison @Kyowa Kirin, Inc.- U.S.
Signup · Get unlimited contacts
WORK HISTORY
Oncology Medical Science Liaison @Kyowa Kirin, Inc.- U.S.
US
In my role as Oncology Medical Science Liaison With Kyowa Kirin I work with Hematologists, Oncologists, and Dermatologists who treat the rare disease Cutaneous T-Cell Lymphoma. We have recently partnered with MEI to co-develop and launch a new drug potentially useful in treating Follicular Lymphoma and Marginal Cell Lymphoma. I cover 18 Academic Institutions in the Upper Midwest states.
EDUCATION
Duke University Graduate School
Masters of Liberal Studies
Duquesne University
Master of Business Administration (MBA)
Duquesne University
Bachelor's of Science in Pharmacy
Duquesne University
Master's of Science in Industrial Pharmacy
SKILLS
ABOUT ED CARR
After earning graduate degrees in Industrial Pharmacy and an MBA, I began my commercial pharmaceutical career at GSK and was promoted 5 times. With the goal of helping to build a new startup pharmaceutical company, I joined Indevus as the Midwest Urology Sales Manager in 2004. After winning President’s Club in 2005/2006, I was promoted to a newly formed role of Director of Managed Care then promoted again in 2007 to Urology National Sales Director. In these roles I developed expertise in Sales Leadership, Medicare Part B Buy and Bill sales, Oncology, and Specialty Pharmaceuticals. I was Urology National Sales Director for Indevus/Endo from 2007 thru 2011. With Endo\'s acquisition of American Medical Systems in the Urology space, I moved into the role of Director of Integrated Sales Strategies then was promoted to Senior Director, Urology Strategic Account role responsible managing C-Suite customer relationships while overseeing the deployment of enterprise-wide resources to help provide solutions to six large group urology practices. This role was eliminated in 2013 with a change in and strategy and executive leadership. In 2014, I moved over to Medical Affairs to a Medical Lead/MSL role for Endo and was responsible for oncology, urology and endocrinology products scientific life cycle management. I left Endo for a Medical Strategic Planning role at Baxalta. After Shire\'s acquisition of Baxalta, I returned to the MSL role at Indivior in the opioid use disorder area and I am currently working as a Oncology Medical Science Liaison in the rare diseases of Cutaneous T Cell Lymphoma and Follicular Lymphoma with Kyowa Kirin.Specialties: Medical Medical Science Liaison | Medical Affairs | Oncology | Launch Excellence | Business and Clinical Acumen | Congress Planning | Project Management | Specialty Pharmaceutical Sales Management | Buy and Bill Selling | Training | Scientific Presentations
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.